Tyler Starr is a Damon Runyon Research Fellow at the Fred Hutchinson Cancer Research Center in Seattle, Washington. Tyler studies the molecular evolutionary arms races between pathogenic viruses and human immunity. Since 2020, he has pioneered experimental methods to model the evolution of the SARS-CoV-2 virus and develop vaccine and antibody therapeutics that counteract this virus’ evolution. This work, which has been published in premier scientific journals including Nature, Science, and Cell, has directly informed pandemic surveillance and therapeutic development.
Tyler completed his PhD in Biochemistry as a National Science Foundation Fellow at the University of Chicago, where he received the “Best Thesis Award” for his work in molecular evolution. Tyler was recently hired as an Assistant Professor of Biochemistry at the University of Utah, where he will continue his research on the evolution of pandemic viruses and immune countermeasures.
